Transcription
Thank you all very much for coming in to listen to the story of UpLyft. I would be remiss if I didn't first start off by acknowledging our founder Anton Simpson, he passed away last week after a fight with cancer wouldn't be here today. And we wouldn't be doing what we are for the world with UpLyft without him. I'm Craig Misrach I've for the last four years been president and CEO for UpLyft and I was hired to lead our commercialization of our novel technology, we are becoming the gold standard in patient transfer in hospitals, senior living facilities and complex rehab. With zero physical exertion required. We are also selling to homes for individuals with disabilities, and limited mobility to independently transfer from bedside to wheelchair. The problems that we're tackling include, there are now 24 million people in the United States that cannot on their own get out of bed or a chair. There is no independency to transfer system that is regulatory cleared in the world. And you can imagine if you're sitting in this audience, what would you pay for independents to get out of bed on your own or a chair and in the hospital systems and nursing homes? We are now talking about the leading driver of workers compensation claim costs in the US health care system at 20 billion annually. back and neck injuries specifically caused from patient lifting by nurses and health care providers. Why is this? Look at how archaic existing technology is. You actually roll patients use cloth slings. Immense caregiver times required at this conference, we talked about nurse staffing shortages and workflow issues relative to that well with the number of injuries and physical exertion that's required. That's one of the main reasons and so we're getting rid of that taking three person lifting teams down to one person that can operate UpLyft. Let me show you. This is our home configuration. This gentleman has lost the use of his legs, he is able to independently transfer out of bed with an UpLyft. We are through FDA, we completed our registration. We've completed our quality systems infrastructure build and GMP manufacturing, we have sold out of all of our inventory. This gentleman is transferring up in UpLyft. This is our independent transfer configuration in a hospital in a senior living facility. Up lift can attach to a portable roller hoist that can go room to room and that can be in a configuration in the home as well. And so as this gentleman is articulating upward, I want you to think about the patient populations. These are some of our customers those that didn't have spinal cord injuries, muscular dystrophy, spinal muscular atrophy, seniors, I can go on and on. We have 15 issued patents that cover this design. And as this gentleman is lowering here on the handlebars, that's where a caregiver a loved one can utilize UpLyft on their own to Assisted Transfer with no physical exertion. I love this slide because it didn't exist six months ago. We're all over the country. We're in consumers homes, we have testimonials. And we've started to build our dealer and distribution network. Every place that we've installed a unit, everyone in this room has seen a stairlift and a commercial for a stairlift we're using the same exact strategy by using those dealers and distributors to expand our footprint around the world are pricing we are at market entry pricing anywhere from 10 to $13,000. That's what customers are paying. And we've already closed a $10 million leasing facility with Kineo finance, who's here at the conference. They're in Switzerland and Silicon Valley that's gonna allow us to deploy our hardware as a service, leasing and rental strategy. At scale over 70% gross margins of the product and in healthcare facilities. We envision building a bariatric unit and an industrial grade medical system. We see price point going up to $20,000 at a direct purchase in the consumer home environment, we're already executing recurring revenue strategies with service plans. assessories and I envision it IoT connectivity where people who have mobility challenges and want to talk to each other about their condition or life or their career can do so. How have we done this? I've talked a lot about data at this conference in digital. I love the fact that we are executing digital marketing to get our consumers to get our customers direct to consumer, less than $500 is what we're spending from a customer acquisition cost standpoint, via Google ads, Instagram, Facebook, and we're going to augment this with like the stairlift industry, direct response TV advertising and more traditional media utility. So back to the health care facilities. It's about health and safety, reducing injuries to nurses making nurses more widely available, lifting teams going from three down to one to transfer a patient out of bed, reducing costs as it relates to workers compensation claims, and having it be a more enjoyable process. I've yet to meet a nurse that says they love lifting other humans out of bed or in any process associated with the facility. This becomes a program. This is over a $30 billion total available market. Think of all the different uses throughout a hospital or a nursing facility. And it's not just bed to wheelchair. If someone's on the floor, you can pick them up with an UpLyft. From a clinical standpoint, frictionless bariatric repositioning. nurses told us they're going to they are using it for linen changes so that we can just sit and UpLyft while the linens are being changed. And so we already have this validation. We're in Piedmont health system in North Carolina that happened in December. Seabrook senior living facility out in New Jersey, it's our most used UpLyft. We're in tuck we're in talks at the sea level of United Hebrew 160 beds in that facility. That's a minimum quarter million dollar purchase order. And a Rosa live home we're in touch at the sea level about their homecare nurses wanting to have UpLyft for patient transfer. We're in based in San Diego we currently manufacture in San Diego, we sold out of all our first production run. We're raising capital here for our second production run to scale manufacturing, sales and distribution. This is my second medical device company I lead as CEO. My first one was in the diabetes space. We raised 15 million and sold that business to sign a care in 2017 and 10. Our dear founder who I mentioned in the beginning, triple degree engineer from MIT 35 year aerospace engineer, I was jaw dropped when I saw the prototype when I signed on to be the CEO. I could not believe it wasn't in professional engineering or manufacturing yet. Rajeed Mahuhltra, some of you may know him in the audience. He is our lead investor his family office regime is a former 20 year McKinsey Consulting partner in Bel Air in Los Angeles, he ran their healthcare division, Bria USD MBA she runs all of our digital marketing and branding. Todd, who is Anton's son has been with us for four years handles our engineering and manufacturing and Scott Seidman, three decade registered nurse selling into institutional facilities. And so look, we have two, we have two things that we talk about from an investment standpoint, we have 2 million left for subscription in our seed preferred stock rounds. So if you are a seed fund, if you are an angel investor, this is not going to be open much longer. If we may, we may close around out early. It's a very reasonable sub million sub 10 million pre money valuation. But if you're also a funder and investor here that's looking to allocate a $10 million check size, we have a series a plan to be able to expand internationally, have product line extensions, and vertically integrate buying service companies to execute direct to consumer sales. But this is about distribution, sales marketing scaling. For our capital, we do not need 2030 $40 million to do that. And so here's some of the growth strategies that we can execute. If we just fill out the seed round with 5 million total in the company, we can be $100 million exit valuation if we raise that extra 10 million, it would be a half a billion dollars. Here's some of our highlights. I'm happy to talk to any of you after this. And please, please welcome us in our mission, whether you're an investor or somebody that knows someone who has a disability or needs help getting out of bed, we welcome you in our mission to help people with limited with limited mobility, restore independence, and also help the caregivers to take care of them. Thank you very much.
Craig Misrach is a 20+ year business executive with escalating levels of C-level experience throughout his career. From 2006-2014, Craig was the Founder, Chairman & CEO of Freedom Meditech, Inc. a diabetes medical device company he led from concept through FDA 510(k) clearance and global commercialization. Freedom Meditech completed a cross border M&A sale in November 2016 to Sinocare, LTD after Craig had helped secure ~$15M in Series A-C Financings for the company. From 2004-2006, Craig was the President & COO of EyeChem, a start-up ophthalmic diabetes medical device company he led while obtaining his full-time MBA from the Darden School of Business at the University of Virginia. Prior to EyeChem, Craig was the Controller for Silvergate Bank where he was responsible for $500M in assets and primary financial reporting responsibility to executive management. Craig is an active CPA in the State of California and started his career at Deloitte & Touche, where he audited various middle market businesses and assisted in the preparation of S-1, 10K, and 10Q filings for public companies.
Craig Misrach is a 20+ year business executive with escalating levels of C-level experience throughout his career. From 2006-2014, Craig was the Founder, Chairman & CEO of Freedom Meditech, Inc. a diabetes medical device company he led from concept through FDA 510(k) clearance and global commercialization. Freedom Meditech completed a cross border M&A sale in November 2016 to Sinocare, LTD after Craig had helped secure ~$15M in Series A-C Financings for the company. From 2004-2006, Craig was the President & COO of EyeChem, a start-up ophthalmic diabetes medical device company he led while obtaining his full-time MBA from the Darden School of Business at the University of Virginia. Prior to EyeChem, Craig was the Controller for Silvergate Bank where he was responsible for $500M in assets and primary financial reporting responsibility to executive management. Craig is an active CPA in the State of California and started his career at Deloitte & Touche, where he audited various middle market businesses and assisted in the preparation of S-1, 10K, and 10Q filings for public companies.
Transcription
Thank you all very much for coming in to listen to the story of UpLyft. I would be remiss if I didn't first start off by acknowledging our founder Anton Simpson, he passed away last week after a fight with cancer wouldn't be here today. And we wouldn't be doing what we are for the world with UpLyft without him. I'm Craig Misrach I've for the last four years been president and CEO for UpLyft and I was hired to lead our commercialization of our novel technology, we are becoming the gold standard in patient transfer in hospitals, senior living facilities and complex rehab. With zero physical exertion required. We are also selling to homes for individuals with disabilities, and limited mobility to independently transfer from bedside to wheelchair. The problems that we're tackling include, there are now 24 million people in the United States that cannot on their own get out of bed or a chair. There is no independency to transfer system that is regulatory cleared in the world. And you can imagine if you're sitting in this audience, what would you pay for independents to get out of bed on your own or a chair and in the hospital systems and nursing homes? We are now talking about the leading driver of workers compensation claim costs in the US health care system at 20 billion annually. back and neck injuries specifically caused from patient lifting by nurses and health care providers. Why is this? Look at how archaic existing technology is. You actually roll patients use cloth slings. Immense caregiver times required at this conference, we talked about nurse staffing shortages and workflow issues relative to that well with the number of injuries and physical exertion that's required. That's one of the main reasons and so we're getting rid of that taking three person lifting teams down to one person that can operate UpLyft. Let me show you. This is our home configuration. This gentleman has lost the use of his legs, he is able to independently transfer out of bed with an UpLyft. We are through FDA, we completed our registration. We've completed our quality systems infrastructure build and GMP manufacturing, we have sold out of all of our inventory. This gentleman is transferring up in UpLyft. This is our independent transfer configuration in a hospital in a senior living facility. Up lift can attach to a portable roller hoist that can go room to room and that can be in a configuration in the home as well. And so as this gentleman is articulating upward, I want you to think about the patient populations. These are some of our customers those that didn't have spinal cord injuries, muscular dystrophy, spinal muscular atrophy, seniors, I can go on and on. We have 15 issued patents that cover this design. And as this gentleman is lowering here on the handlebars, that's where a caregiver a loved one can utilize UpLyft on their own to Assisted Transfer with no physical exertion. I love this slide because it didn't exist six months ago. We're all over the country. We're in consumers homes, we have testimonials. And we've started to build our dealer and distribution network. Every place that we've installed a unit, everyone in this room has seen a stairlift and a commercial for a stairlift we're using the same exact strategy by using those dealers and distributors to expand our footprint around the world are pricing we are at market entry pricing anywhere from 10 to $13,000. That's what customers are paying. And we've already closed a $10 million leasing facility with Kineo finance, who's here at the conference. They're in Switzerland and Silicon Valley that's gonna allow us to deploy our hardware as a service, leasing and rental strategy. At scale over 70% gross margins of the product and in healthcare facilities. We envision building a bariatric unit and an industrial grade medical system. We see price point going up to $20,000 at a direct purchase in the consumer home environment, we're already executing recurring revenue strategies with service plans. assessories and I envision it IoT connectivity where people who have mobility challenges and want to talk to each other about their condition or life or their career can do so. How have we done this? I've talked a lot about data at this conference in digital. I love the fact that we are executing digital marketing to get our consumers to get our customers direct to consumer, less than $500 is what we're spending from a customer acquisition cost standpoint, via Google ads, Instagram, Facebook, and we're going to augment this with like the stairlift industry, direct response TV advertising and more traditional media utility. So back to the health care facilities. It's about health and safety, reducing injuries to nurses making nurses more widely available, lifting teams going from three down to one to transfer a patient out of bed, reducing costs as it relates to workers compensation claims, and having it be a more enjoyable process. I've yet to meet a nurse that says they love lifting other humans out of bed or in any process associated with the facility. This becomes a program. This is over a $30 billion total available market. Think of all the different uses throughout a hospital or a nursing facility. And it's not just bed to wheelchair. If someone's on the floor, you can pick them up with an UpLyft. From a clinical standpoint, frictionless bariatric repositioning. nurses told us they're going to they are using it for linen changes so that we can just sit and UpLyft while the linens are being changed. And so we already have this validation. We're in Piedmont health system in North Carolina that happened in December. Seabrook senior living facility out in New Jersey, it's our most used UpLyft. We're in tuck we're in talks at the sea level of United Hebrew 160 beds in that facility. That's a minimum quarter million dollar purchase order. And a Rosa live home we're in touch at the sea level about their homecare nurses wanting to have UpLyft for patient transfer. We're in based in San Diego we currently manufacture in San Diego, we sold out of all our first production run. We're raising capital here for our second production run to scale manufacturing, sales and distribution. This is my second medical device company I lead as CEO. My first one was in the diabetes space. We raised 15 million and sold that business to sign a care in 2017 and 10. Our dear founder who I mentioned in the beginning, triple degree engineer from MIT 35 year aerospace engineer, I was jaw dropped when I saw the prototype when I signed on to be the CEO. I could not believe it wasn't in professional engineering or manufacturing yet. Rajeed Mahuhltra, some of you may know him in the audience. He is our lead investor his family office regime is a former 20 year McKinsey Consulting partner in Bel Air in Los Angeles, he ran their healthcare division, Bria USD MBA she runs all of our digital marketing and branding. Todd, who is Anton's son has been with us for four years handles our engineering and manufacturing and Scott Seidman, three decade registered nurse selling into institutional facilities. And so look, we have two, we have two things that we talk about from an investment standpoint, we have 2 million left for subscription in our seed preferred stock rounds. So if you are a seed fund, if you are an angel investor, this is not going to be open much longer. If we may, we may close around out early. It's a very reasonable sub million sub 10 million pre money valuation. But if you're also a funder and investor here that's looking to allocate a $10 million check size, we have a series a plan to be able to expand internationally, have product line extensions, and vertically integrate buying service companies to execute direct to consumer sales. But this is about distribution, sales marketing scaling. For our capital, we do not need 2030 $40 million to do that. And so here's some of the growth strategies that we can execute. If we just fill out the seed round with 5 million total in the company, we can be $100 million exit valuation if we raise that extra 10 million, it would be a half a billion dollars. Here's some of our highlights. I'm happy to talk to any of you after this. And please, please welcome us in our mission, whether you're an investor or somebody that knows someone who has a disability or needs help getting out of bed, we welcome you in our mission to help people with limited with limited mobility, restore independence, and also help the caregivers to take care of them. Thank you very much.
Market Intelligence
Schedule an exploratory call
Request Info17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy